Estimands and Their Estimators for Clinical Trials Impacted by the COVID-19 Pandemic Kelly Van Lancker, Johns Hopkins University, Bloomberg School of Public Health, US and Ghent University, Belgium; Sergey Tarima, Division of Biostatistics, Medical College of Wisconsin; Jonathan Bartlett, University of Bath; Madeline Bauer, Division of Infectious Diseases, Keck School of Medicine, University of Southern Californi; Bharani Bharani-Dharan, Novartis Pharmaceuticals; Frank Bretz, Novartis; Nancy Flournoy, University of Missouri; Hege Michiels, Ghent University; Camila Olarte Parra, University of Bath; James Landis Rosenberger, Penn State and NISS; Suzie Cro, Imperial Clinical Trials Unit, Imperial College London
Discussant: Wanjie Sun, The US FDA
Discussant: Tianmeng Lyu, Novartis
Video Available to all JSM Registered Attendees. Please login to view.